Previous studies have shown that melatonin treatment increases the susceptibility of retinal photoreceptors to light-induced cell death. The purpose of this study was to evaluate under various conditions the potential toxicity of dietary melatonin on retinal photoreceptors. Male and female Fischer 344 (non-pigmented) and LongeEvans (pigmented) rats were treated with daily single doses of melatonin by gavage for a period of 14 days early in the light period or early in the dark period. In another group, rats were treated 3 times per week with melatonin early in the light period, and then exposed to high intensity illumination (1000e1500 lx; HII) for 2 h, and then returned to the normal cyclic lighting regime. At the end of the treatment periods, morphometric measurements of outer nuclear layer thickness (ONL; the layer containing the photoreceptor cell nuclei) were made at specific loci throughout the retinas. In male and female non-pigmented Fischer rats, melatonin administration increased the degree of photoreceptor cell death when administered during the nighttime and during the day when followed by exposure to HII. There were some modest effects of melatonin on photoreceptor cell death when administered to Fischer rats during the day or night without exposure to HII. Melatonin treatment caused increases in the degree of photoreceptor cell death when administered in the night to male pigmented LongeEvans rats, but melatonin administration during the day, either with or without exposure to HII, had little if any effect on photoreceptor cell survival. In pigmented female LongeEvans rats, melatonin administration did not appear to have significant effects on photoreceptor cell death in any treatment group. The results of this study confirm and extend previous reports that melatonin increases the susceptibility of photoreceptors to light-induced cell death in non-pigmented rats. It further suggests that during the dark period, melatonin administration alone (i.e., no HII exposure) to pigmented male rats may have a toxic effect on retinal cells. These results suggest that dietary melatonin, in combination with a brief exposure to high intensity illumination, induces cellular disruption in a small number of photoreceptors. Chronic exposure to natural or artificial light and simultaneous intake of melatonin may potentially contribute to a significant loss of photoreceptor cells in the aging retina.
Introduction
The major hormone of the pineal gland, melatonin (N-acetyl-5-methoxytryptamine) is also synthesized by retinal photoreceptors (Cahill and Besharse, 1992; Green et al., 1995; Guerlotte et al., 1996; Wiechmann, 1996; Wiechmann and Craft, 1993) under a cyclic rhythm with peak levels occurring during the dark period (Pang et al., 1980; Wiechmann et al., 1986) . Melatonin may play an important role in dark adaptation; it alters the sensitivity of the central visual system to light (Reuss and Kiefer, 1989; Semm and Vollrath, 1982) , and increases the sensitivity of horizontal cells to light in the salamander retina (Wiechmann et al., 1988) . Melatonin, synthesized at night, may bind to receptors in the retina to increase the sensitivity of the visual system when photic input is low, and thus facilitate retinal dark adaptation by increasing horizontal cell coupling through inhibition of dopamine release (Krizaj and Witkovsky, 1993) and perhaps by stimulating the photoreceptors directly (Cosci et al., 1997; Wiechmann et al., 2003) .
Melatonin treatment given immediately prior to continuous light exposure increases the degree of light-induced photoreceptor cell death in albino rats (Bubenik and Purtill, 1980; Wiechmann and O'Steen, 1992) , and a melatonin receptor antagonist protects photoreceptors from light-induced damage (Sugawara et al., 1998) , thus demonstrating that the effect of melatonin is mediated through a retinal melatonin receptor. Because one function of melatonin may be to enhance the sensitivity of the retina to light as part of a dark-adaptation mechanism, an undesirable consequence of this may be an increased sensitivity to the damaging effects of light.
The recent discovery that the retinal photoreceptor cells express melatonin receptors (Scher et al., 2002; Wiechmann and Wirsig-Wiechmann, 2001 ) is intriguing in light of the overwhelming evidence that photoreceptors are the sites of retinal melatonin synthesis (Cahill and Besharse, 1992; Guerlotte et al., 1996; Wiechmann, 1996; Wiechmann and Craft, 1993; Niki et al., 1998) . Although signals from the inner retina undoubtedly play a major role in the circadian activities of retinal photoreceptors (Boatright et al., 1994; Dubocovich, 1983; Dubocovich and Takahashi, 1987) , intracrine (autocrine) melatonin signaling in photoreceptors likely contributes substantially to circadian regulation in the retina.
Inappropriate (i.e.; daytime) exposure of retinal cells to melatonin may be detrimental to photoreceptor cell survival, as supported by reports that melatonin increases the degree of light-induced photoreceptor cell death (Bubenik and Purtill, 1980; Wiechmann and O'Steen, 1992) . The many Americans that self-administer dietary melatonin may therefore be at a higher risk for developing retinal degenerations that ensue from the death of photoreceptors. Chronic exposure of the retina to melatonin at inappropriate times of day and lighting conditions may increase the risk of susceptibility of photoreceptors to damage by environmental illumination. There has been a dramatic increase in self-prescribed melatonin in recent years, and melatonin is widely available in grocery, drug, and health food stores, and is currently unregulated in the United States. The self medication may exceed recommended maximum levels (3 mg/person) and represents a large uncontrolled human experiment. Based on a previous study (Wiechmann and O'Steen, 1992) , systematic animal studies were undertaken to test the hypotheses that melatonin exposure during exposure to light may cause damage and death of retinal photoreceptors. The major ocular toxicity results of a 14-day melatonin toxicity study are reported.
Materials and methods

Animal treatments
Two-month-old male and female non-pigmented Fischer 344 (Taconic, Germantown, NY) and LongeEvans (pigmented) rats (Charles River Laboratories, Raleigh, NC), which were born and reared under a 12 h light (480 lx at 3.5 feet above cage level)/12 h dark lighting cycle, were randomized into three groups and maintained for 10e14 days on a full spectrum cyclic lighting regime of 12 h light/12 h dark (12L/ 12D: 6 AM lights on/6 PM lights off). The illumination intensity during the light period ranged from 10 to 40 lx. During the 14-day treatment period, ten animals per sex per strain received melatonin by gavage in 0.5% methylcellulose containing 0.25% ethanol (Table 1) . The melatonin dosages were 5, 50, 5000, 50,000, and 200,000 mg/kg of body weight. This research adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, the Laboratory Animal Welfare Act of 1966 and adhered to the principles enunciated in the ''Guide for the Care and Use of Laboratory Animals'' NRC, 1996, and the 1964 Declaration of Helsinki and ''Principles of Laboratory Animal Care '', (NIH publication no. 86-23, revised 1985) .
In the day treatment groups, melatonin was administered between 9 and 11 AM (i.e., 3e5 h after lights on) during the light phase (10e40 lx at cage level), and maintained on the cyclic lighting regime. In the night treatment group, the animals were entrained to a reverse lighting cycle (12D/12L: 6 AM lights off/ 6PM lights on; 10e40 lx). Melatonin was administered between 8 and 10 AM (i.e., 2e4 h after lights off) under dim red light (0.1 lx) and maintained on the reverse cyclic lighting regime for the remainder of the study. The treatment schedule was 12 days of melatonin doses, not including weekend days.
In the high intensity illumination (HII) treatment groups, melatonin was administered between 9 and 11 AM (i.e., 3e 5 h after lights on) three times per week (M, W, F) during the light phase (10e40 lx), then were immediately exposed to high intensity illumination (HII; 1000 lx for the Fischer rats, 1500 lx for the LongeEvans rats) for 2 h at room temperature, then returned to the normal cyclic lighting regime until the next treatment. The pupils were not dilated for HII exposure, since one goal of the study was to approximate normal lighting conditions. The higher light intensity for pigmented rats was used because it is well known that a higher intensity illumination is required to induce retinal damage in pigmented rats than in albino rats. In humans, 2500 lx is sufficient to shift circadian rhythms, while 500 lx does not influence the endogenous production of melatonin (Lewy et al., 1980) . The illuminances and exposure times were chosen to mimic the conditions of the human eye in the presence of high and low dosages of melatonin and exposed to intermittent bright sunlight. The low concentrations of melatonin were used to mimic normal dosages for taken as a sleep aid and high melatonin concentrations were used to mimic the dosages that are used in the treatment of cancer patients.
Tissue preparation
At the end of the treatment period, animals were maintained on cyclic lighting for 12 days to allow the retinal tissue to recover and eliminate any cellular debris from apoptotic photoreceptor cells that may have accumulated during the melatonin and HII treatments. The right eye from each animal was enucleated from euthanized animals, placed into Davidson's fixative (31% ethanol, 22% formalin, and 12% glacial acetic acid, pH 3.5e4.0) for several hours, and then further fixed in 10% neutralized formalin. The tissues were embedded in paraffin wax, sectioned on the anterioreposterior axis at 7 mm thickness, mounted onto glass sides, stained with hematoxylin and eosin, and cover-slipped.
Morphometric measurements
Retinas from a total of 720 animals were analyzed in the 14-day study. Each group was composed of 10 rats (10 rats Â 2 sexes Â 2 strains Â 3 groups Â 6 dosages ¼ 720 eyes). Three mid-sagittal eye sections (containing the center of the optic nerve) from the right eye of each rat were analyzed. Morphometric measurements of outer nuclear layer thickness (ONL, the layer containing the photoreceptor cell nuclei) (Fig. 1 ) were made at 10 specific sites spanning the entire circumference of the retina (loci 1e5, superior quadrant; loci 6e10, inferior quadrant) on sections of the mid-sagittal region of the retina similar to the method described previously (Wiechmann and O'Steen, 1992) . The relative thickness of the ONL is a direct measurement of the degree of photoreceptor cell death (Michon et al., 1991) , and has been used previously to measure the effect of melatonin and its receptor antagonist on HII-induced photoreceptor cell death (Wiechmann and O'Steen, 1992; Sugawara et al., 1998) . We have previously validated ONL measurement as a direct reflection of number photoreceptor cell nuclei in (unpublished observations), in which ONL thickness measurements were performed by counting columns of photoreceptor nuclei, then converting the value to ONL thickness based on the average nuclear diameter. It was determined that the number of photoreceptor cell nuclei and the ONL thickness were reduced by melatonin to the same degree. The average values of each set of 3 measurements (one measurement at each locus per section) were recorded as the ONL thickness for the particular animal at the specific locus (Fig. 1) . Therefore, a total of 21,600 separate measurements were performed on the specimens analyzed in this study (720 slides Â 3 sections Â 10 loci ¼ 21,600 measurements).
To measure the ONL thickness, the center of the optic nerve head was selected as the beginning reference point (Fig. 1) . The field of view in the microscope (Nikon Optiphot; Tokyo, Japan) using a 20Â objective lens was 363 mm (Fig. 1) , as measured by a calibrated ocular grid micrometer. The reference point in the center of the optic nerve head was placed at the edge of the field of view, then the center of the field of view was viewed using a 40Â objective lens, and the ONL thickness was measured using a calibrated ocular grid micrometer. The measurement was then entered onto a Microsoft Excel spreadsheet as the measurement at retinal locus number 5 (Fig. 1 ). For the next measurement, a landmark site at the opposite edge of the optic nerve head (reference point) was identified at 20Â magnification, and the slide was moved to place that landmark at the opposite edge of the field of view (i.e., where the starting reference point used to be). This effectively shifted the center of the field of view 363 mm (Fig. 1) . The center of the field of view was viewed using a 40Â objective lens, and the ONL thickness was measured and recorded as before. This process was repeated three more times until the entire expanse of the superior quadrant was measured, then the entire process described for the superior quadrant was repeated for the inferior quadrant. This method of analysis provided a measurement of ONL thickness at uniform loci from superior peripheral (loci 1e5) to central (optic nerve) to inferior peripheral (loci 6e10). Measurement of many specific loci throughout the retina was crucial for accurate analysis of photoreceptor cell death (thinning of the ONL), since the ONL thickness is significantly greater in the more central regions of the retina than in the peripheral regions. Additionally, subjective estimates were made on the relative degrees of photoreceptor cell death by assigning the following symbols: À, no effect; þ, small effect; þþ, moderate effect; þþþ, severe effect. These subjective estimates took into account the number of melatonin dosages that caused an effect, the number of retinal loci that were affected, and the percent reduction of ONL thickness in the affected loci.
Statistical analysis
Statistical analysis was performed separately for each sex and strain. Averages of the three measurements of ONL thickness for each animal at each specific locus were the endpoints of this analysis. Descriptive statistics for each effective melatonin dosage group are reported at each locus for each lighting treatment group.
A repeated measures analysis of variance (ANOVA) model was fitted to the ONL thickness measurements in order to evaluate the effects of melatonin and lighting condition in the study rats. The mixed effects model included main effects for melatonin dosage, locus, lighting treatment, two-way interactions between melatonin dosage and lighting treatment, melatonin dosage and locus, and lighting treatment and locus, and a three-way interaction among melatonin dosage, lighting treatment, and locus as fixed effects, and animal as a random effect. The errors from the same animal at different loci were assumed to be correlated, and an autoregressive AR(1) covariance structure was assumed. The degrees of freedom for the tests of fixed effects were computed using Kenward and Roger's method (Kenward and Roger, 1997 ). Fixed effects were tested by overall F-tests at the 0.05 significance level.
If the effects for melatonin dosage or lighting treatment were found to be significant, then additional tests were performed to investigate these effects. Initially, a statistical contrast was used to test for any differences in ONL thickness among the three lighting treatments in the absence of melatonin. This contrast compared the mean ONL thickness over all loci at the control (0 mg/kg melatonin) dosage among the three lighting treatments. If significant differences were found in this comparison, additional contrasts were used to compare mean ONL thickness over all loci at the control dosage for each pair of lighting treatments. A Bonferroni adjustment was used to maintain a 0.05 level of significance over these comparisons (that is, the significance level used for each pair-wise comparison was 0.05/3 ¼ 0.0167). Significant differences between lighting treatments at the control dosage implies that lighting treatment alone had an effect on ONL thickness and precluded testing for general melatonin effects over all treatments. When this occurred, melatonin effects were investigated within each lighting treatment.
If there were no effects due to lighting treatment alone and no significant interactions between melatonin dosage and lighting treatment, then the following tests were performed to examine the main effects of melatonin dosage and lighting treatment. If the main effect for melatonin dosage was significant, Dunnett's test was used to compare the mean at each melatonin dosage over all lighting treatment groups and loci to the overall control mean. Dunnett's test is a multiple comparisons procedure that maintains a 0.05 significance level over all comparisons. If the main effect for lighting treatment was significant, then t-tests were used to compare the means of each pair of lighting treatments over all melatonin dosages and loci. A Bonferroni adjustment was used to maintain a 0.05 level of significance over these comparisons (that is, the significance level used for each pair-wise comparison was 0.05/ 3 ¼ 0.0167). Similar tests were not performed to examine the effect of locus, as this effect was expected to be significant because the ONL is thinner at positions 1 and 10.
To further investigate the effects of melatonin on photoreceptor cell death (ONL thickness), three additional sets of tests were performed to examine: (1) the effect of melatonin within each lighting treatment; (2) the effect of melatonin at each locus (if there were no effects due to lighting treatment alone); and (3) the effect of melatonin at each locus within each lighting treatment. The following approach was used for these tests. First, F-tests were conducted to determine whether a melatonin effect was evident for a specified lighting treatment, locus, or combination of interest. The significance level for each set of tests was adjusted using Hochberg and Benjamini's method for multiple testing at an overall 0.05 level. If a significant melatonin effect was found, then pair-wise comparisons were performed to determine which (if any) of the five melatonin dosage group means differed significantly from the control mean within the given treatment/locus of interest, at a Bonferroni-adjusted 0.05 significance level (that is, the significance level for each pair-wise comparison to the control was 0.05/5 ¼ 0.01). Other differences among the melatonin dosage group means could contribute to a significant F-test, but were not of interest in establishing the effects of melatonin.
The ANOVA models and comparisons were performed using PROC MIXED in SAS version 8 (SAS Institute, Inc., 1999a). The Hochberg and Benjamini adjustment for multiple comparisons was conducted using PROC MULTTEST in SAS version 8 (SAS Institute, Inc., 1999b).
Results
LongeEvans and Fischer 344 rats given 5e200,000 mg/kg of melatonin for 14-day treatment period followed by a 12-day recovery period showed no treatment effects on terminal body weights, organ weights, gross pathology or histopathology. In non-HII-exposed rats, the ONL thicknesses were normal (Fig. 2) , indicating that the photoreceptors were undamaged, whereas HII-exposed animals showed a small decrease (approximately 5%) in ONL thickness, indicating that a moderate level of photoreceptor cell death occurred in this lighting regime (Fig. 3). 3.1. 14-day study of male Fischer 344 rats
Tests of fixed effects indicated that there were significant melatonin dosage and locus effects on the 14-day-treated male Fischer 344 rats, but that lighting treatment had only a marginal effect on ONL thickness ( p ¼ 0.0811). All twoway interactions were statistically significant, indicating that the observed effects were not consistent over all levels of the other variables.
Day treatment group
Melatonin administration during the early daytime increased photoreceptor cell death at dosages of 5000 and 50,000 mg/kg in 14-day-treated male Fischer 344 rats ( Table 2) . The approximate percentage decrease of photoreceptor cells (ONL thickness) in the two affected loci (7 and 9) in both of the effective melatonin dosages was about 3e7%. Statistical significance was based upon comparison of melatonin-affected loci compared to the identical set of loci in the control (0 mg/kg) group (Table 2) . Evaluation of the effect of lighting treatment in the absence of melatonin indicated that there were significant differences in mean ONL thickness due to lighting treatment alone.
Night treatment group
Melatonin administration during the early nighttime in 14-day-treated male Fischer 344 rats had no significant effect on photoreceptor cell death. However, at a melatonin dosage of 200,000 mg/kg, the ONL thickness was significantly higher compared to the untreated group (0 mg/kg; p < 0.05; Table 2 ) at retinal locus 6 (Table 2 ). This is suggestive of a protective effect of melatonin on photoreceptor cells, but since there was no exposure to high intensity illumination, it is not a plausible outcome, since it would imply that new photoreceptors were generated during the treatment period. Since photoreceptor cells are post-mitotic, new photoreceptor cells cannot be generated. These results therefore provide an illustration of the degree of error to expect in these studies. Another explanation is that some tissue swelling occurred as a result of melatonin treatment.
High intensity illumination (HII) treatment group
Melatonin administration (three times per week on alternating days) during the early daytime followed by 2 h of high intensity illumination (HII; 1000 lx) in 14-day-treated male Fischer 344 rats increased photoreceptor cell death by 6.8% at all melatonin dosage groups except the 5000 mg/kg dosage . This retina is from a Fischer female rat that was treated on alternate days for 14 days with 50 mg/kg of melatonin, then immediately exposed to 1000 lx illumination for 2 h at room temperature. Note that the ONL in this retina is thinner than the ONL of the control retina seen in (A). Magnification bar, 50 mm. Female Long-Evans rats in the Day group were maintained on a normal cyclic lighting regime during the 14 day treatment period and an additional 2 weeks of recovery time. Rats in the HII group were exposed to high intensity illumination for 2 h 3 times per week during the 14 week treatment period, and then were returned to the normal cyclic lighting regime for 2 weeks of recovery. Melatonin was not administered to these control animals (0 mg/kg group). Measurements of ONL thickness were made at 10 different loci of the superior peripheral, central, and inferior peripheral retina. The ONL thickness is consistently higher in the Day treatment group when compared to the HII treatment group, indicating that a modest degree of photoreceptor damage results from brief exposures to high intensity illumination The paired means of all loci in each group are statistically significant (p < 0.05).
group at retinal locus 5 when compared to the HII controls (Table 2 ; Fig. 4 ).
14-day study of female Fischer 344 rats
Evaluation of the effect of treatment in the absence of melatonin indicated that there were no significant differences in mean ONL thickness due to lighting treatment alone in 14-day-treated female Fischer 344 rats.
Day treatment group
Melatonin administration during the early daytime had a minimal significant effect on the enhancement of photoreceptor cell death at the 200,000 mg/kg dosage group in 14-day-treated female Fischer 344 rats (Table 2 ). This contrasts with the increased photoreceptor cell death at dosages of 5000 and 50,000 mg/kg at two loci in the Fischer male rats, which is suggestive of a small gender difference in responsiveness to melatonin administration in the daytime.
Night treatment group
Melatonin administration during the early nighttime increased the level of photoreceptor cell death by about 5e7% in the 50,000 mg/kg dosage group compared to the control Effect of various dosages of melatonin on photoreceptor cell death under different lighting regimes, sexes, and strains of rats. In the non-pigmented Fischer male rats, melatonin causes an increase (þ) in photoreceptor (PH) cell death in the day (þ) and high intensity illumination (HII, þþ) treatment groups, and in females in the night (þ) and HII treatment (þþþ) groups. In pigmented LongeEvans rats, melatonin causes an increase in photoreceptor cell death in males in the night (þþþ) group. The scoring of the increased photoreceptor cell death (À, þ, þþ, þþþ) are subjective estimates. The statistically significant effective dosages of melatonin (compared to non-melatonin treated control group in each treatment group, are shown in column two. Loci 1e5 are on the superior quadrant, and loci 6e 10 are on the inferior quadrant. The affected loci of each effective melatonin dosage in each treatment group are shown in the third column, and their respective % reductions in ONL thickness are shown in the fourth column. F-tests were used to test for significant melatonin effects over all loci within lighting treatments and melatonin effect at each locus within lighting treatment where the Benjamini and Hochberg multiple comparison adjustment method was used to control the overall error rate at the 0.05 level. When significant melatonin effects were present, pair-wise comparisons were made between each of the five melatonin dosage groups and the control group within the lighting treatment group. Each pair-wise comparison was performed using Bonferroni-adjustment method, to ensure that the overall error rate associated with the five comparisons was no greater than 0.05. The effective melatonin dosages at which the ONL thickness differed significantly from the control at the Bonferroni-adjusted 0.05 level are in the second column. Fig. 4 . Outer nuclear layer (ONL) thickness of Fischer 344 male rats in response to melatonin treatment and HII exposure. Melatonin was administered by gavage during the daytime, and then the rats were exposed to high intensity illumination for 2 h then were returned to the normal cyclic lighting regime over a period of 14 days. Measurements of ONL thickness were made at 10 different loci of the superior peripheral, central, and inferior peripheral retina. All dosages of melatonin caused a reduction in ONL thickness compared to the 0 mg/kg control group, although only the 5, 50,000, and 200,000 mg/kg groups were statistically significant (p < 0.05).
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group at retinal loci 6, 7, and 8 in 14-day-treated female Fischer 344 rats ( Table 2 ). The mean of the ONL thickness in the 5000 mg/kg dosage group at retinal locus 2 was also significantly less (10.2%) than those of the control groups at retinal locus 2 (Table 2) .
High intensity illumination (HII) treatment group
Melatonin administration (3Â per week) during the early daytime followed by 2 h of HII (1000 lx) in 14-day-treated female Fischer 344 rats increased photoreceptor cell death at all dosages except at the highest dosage of 200,000 mg/kg (Fig. 5) . The approximate percentage decrease of photoreceptor cells in the affected loci (6, 7, and 8) was about 5e7%. The degree of melatonin-mediated photoreceptor cell loss in the female Fischer rats groups was therefore highest in the HIItreated group.
14-day study of male LongeEvans rats
Tests of fixed effects indicated that there were significant melatonin dosage and locus effects in 14-day-treated male LongeEvans rats, but that lighting treatment had only a marginal effect on ONL thickness ( p ¼ 0.0811). All two-way interactions were statistically significant, indicating that the observed effects were not consistent over all levels of the other variables. Evaluation of the effect of lighting treatment in the absence of melatonin indicated that there were significant differences in mean ONL thickness due to lighting treatment alone.
Day treatment group
Melatonin administration during the early daytime had no significant effect on photoreceptor cell death at any dosage in 14-day-treated male LongeEvans rats (Table 2 ). This contrasts with the increased photoreceptor cell death at dosages of 5000 and 50,000 mg/kg at two loci in the Fischer male rats, which is suggestive of mild strain or pigmentation differences in responsiveness to melatonin administration.
Night treatment group
Melatonin administration during the early nighttime increased photoreceptor cell death at the 50, 5000, and 200,000 mg/kg dosage groups in 14-day-treated male Longe Evans rats (Table 2; Fig. 6 ). The approximate percentage decrease of photoreceptor cells in retinal loci 6e9 of all of the effective melatonin dosages in the affected loci was about 5e9% ( Table 2 ). The approximate level and distribution of photoreceptor cell death in the affected groups were quite consistent among the affected groups (Fig. 6) .
Light (HII) treatment group
Melatonin administration (3Â per week) during the early daytime followed by 2 h of HII (1500 lx) increased photoreceptor cell death at a dosage of 200,000 mg/kg in 14-daytreated male LongeEvans rats ( Table 2 ). The percentage decrease of photoreceptor cells in the affected locus 5 was 7.5%. Surprisingly, melatonin treatment early in the dark period and without exposure to HII in male LongeEvans (non-pigmented) rats caused the most photoreceptor cell death as compared to the day and HII exposed groups.
14-day study LongeEvans females
Tests of fixed effects indicated that there were significant lighting treatment and locus effects in 14-day-treated female LongeEvans rats, but that melatonin dosage did not have Fig. 5 . Outer nuclear layer (ONL) thickness of Fischer 344 male rats in response to melatonin treatment and HII exposure. Melatonin was administered by gavage during the daytime, and then the rats were exposed to high intensity illumination for 2 h then were returned to the normal cyclic lighting regime over a period of 14 days. Measurements of ONL thickness were made at 10 different loci of the superior peripheral, central, and inferior peripheral retina. All dosages of melatonin caused a reduction in ONL thickness compared to the 0 mg/kg control group, although only the 5,50,000, and 200,000 mg/kg groups were statistically significant (p < 0.05). Fig. 6. Outer nuclear layer (ONL) thickness of Long Evans male rats in response to melatonin treatment during the night. Melatonin was administered by gavage at nighttime over a period of 14 days. Measurements of ONL thickness were made at 10 different loci of the superior peripheral, central, and inferior peripheral retina. All dosages of melatonin caused a reduction in ONL thickness compared to the 0 mg/kg control group ( p < 0.05), although only the 5000 mg/kg group was not statistically significant. a statistically significant effect on ONL thickness. The twoway interaction between locus and lighting treatment was statistically significant. The two-way interaction between lighting treatment and melatonin dosage and the three-way interaction were marginally significant. Evaluation of the effect of lighting treatment in the absence of melatonin indicated that there were significant differences in mean ONL thickness due to lighting treatment alone. Further analysis indicated that the mean ONL thickness in the day treatment group was significantly greater than that of the HII treatment group, for control animals. No significant melatonin effects were observed within any of the three lighting treatments. Within lighting treatment and locus, significant melatonin effects were observed at some loci for the day and night treatment groups, but none of the five melatonin dosage groups were significantly different from the control groups at these loci.
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Melatonin administration during the early daytime, early nighttime, and during the early daytime followed by 2 h of HII (1500 lx) had no significant effect on photoreceptor cell death at any dosage in any of the female LongeEvans treatment groups.
In summary, while there were statistically significant differences in the mean ONL thickness of control animals between lighting conditions within sexes and strains, these differences indicated different responses for each sex and strain combination. No ONL mean of any control group varied more than 10% from any of the other control mean regardless of sex, strain or lighting condition.
Not only did the ONL means of control animals vary less than 10% between control groups but any ONL mean at any one locus for any melatonin dosage did not vary more than 10% from their respective control. While there were occasional statistically significant differences between ONL means, no melatonin-related trends were similar between sexes within a strain or within sexes between strains.
Discussion
The purpose of this study was to evaluate the potential toxicity of dietary melatonin on retinal photoreceptors. Previous studies (Bubenik and Purtill, 1980; Wiechmann and O'Steen, 1992; Sugawara et al., 1998) have suggested a potential detrimental effect of melatonin on photoreceptor cell survival in albino rats, and many reports suggest that melatonin may be beneficial for combating cancer, Lissoni et al., 1994) , alleviating jet lag (Claustrat et al., 1992; Petrie et al., 1989) and entraining circadian rhythms (Petrie et al., 1989; Armstrong, 1989) such as sleep patterns (Reiter, 1980; Dollins et al., 1994; Zhdanova et al., 1995) . These perceived benefits have motivated many Americans to self-administer melatonin. The access to melatonin is presently unregulated in the United States, and there is some concern in the scientific community that a potential health risk may exist for some individuals that self-administer melatonin at inappropriate dosages and under inappropriate environmental lighting conditions, and that an ocular melatonin toxicity study was needed to assess these possibilities. In the present study, melatonin was administered orally to rats in a range of dosages from low dosages of 5 and 50 mg/kg, in which 50 mg/kg is approximately equivalent to the recommended 3 mg human dose for treatment of jet lag and insomnia, and higher dosages (50,000 and 200,000 mg/kg), which are similar to what cancer patients may receive .
In this 14-day study, melatonin caused an increase in the degree of photoreceptor cell death when administered during the daytime to male Fischer 344 rats (non-pigmented), either with or without exposure to HII (high intensity illumination; day and HII groups), but melatonin administration at night essentially had no effect, since the one effective melatonin dosage at one affected retinal locus showed an increase in ONL thickness, which is implausible since photoreceptors cannot replicate, although tissue swelling may offer an explanation in this case. In the female Fischer rats, there was a negligible effect of one or two dosages of melatonin on photoreceptor cell death when administered during the day or night, but melatonin did cause a significant increase in photoreceptor cell death in female rats treated at daytime with melatonin then followed by 2 h of HII (HII group). The female Fischer rats appeared to have more photoreceptor cell death than the males when melatonin was administered alone during the night (night group). When treated with melatonin in daytime followed by 2 h of HII (HII group), female Fischer rats also had a statistically higher degree of photoreceptor cell death than did the male rats, as indicated by the number of retinal loci affected. The results of this component of the study confirm previous reports that melatonin increases the susceptibility of photoreceptor cells to HII-induced cell death in albino rats (Bubenik and Purtill, 1980; Wiechmann and O'Steen, 1992; Sugawara et al., 1998) . The degree of HII-induced cell death was lower in this study compared to previous studies (Bubenik and Purtill, 1980; Wiechmann and O'Steen, 1992) . This was predicted, since the light exposure regime was quite different; our previous study (Wiechmann and O'Steen, 1992) used 1600 lx continuously for 24 h at 30 C, whereas the present study used only 1000 lx for 2 h (3Â per week for 2 weeks) at room temperature (RT). The HII conditions in this toxicity study were used in an attempt to more closely mimic the intensity and duration of natural and artificial light to which humans may be routinely exposed.
In male LongeEvans (pigmented) rats, melatonin administration alone had no effect on the degree of photoreceptor cell death when administered during the day (day group), but it did increase photoreceptor cell death when administered alone at night. We speculate that perhaps the increased photoreceptor cell death that occurs when melatonin is administered alone at night is because the high levels of melatonin resulting from the gavage administration initiates a down-regulation of the melatonin receptors, which would make the receptors unavailable for stimulation by the endogenous nocturnal levels of retinal melatonin. This would make the photoreceptor cells unresponsive to the beneficial role of melatonin at night, such as preparing the retina for the assault of light that occurs in the morning. Another possibility is that high endogenous melatonin levels at night are necessary for proper function of the photoreceptors, but if melatonin levels are greatly increased above the normal endogenous melatonin levels, this could be toxic to the photoreceptors.
The major conclusions that may be derived from this study are that: (1) melatonin administered during the day followed by immediate exposure to moderate levels and duration of HII increases the degree of photoreceptor cell death in a non-pigmented rat strain, and (2) melatonin administered at night to pigmented male rats appears to be toxic to photoreceptors. The results of this study also confirm previous reports that melatonin increases the susceptibility of photoreceptor cells to HII-induced cell death in albino rats (Bubenik and Purtill, 1980; Wiechmann and O'Steen, 1992; Sugawara et al., 1998) .
When different groups of animals such as males vs. females and LongeEvans vs. Fischer rats were compared, the results suggested some possible gender and/or strain differences in sensitivity to some dosages of melatonin administration. Male LongeEvans (pigmented) appeared to be more sensitive to melatonin treatment at night than were the LongeEvans females. Also, Fischer male and female rats appeared to be more sensitive to the toxic effects of melatonin treatment followed by HII than were the LongeEvans male and female rats. This is consistent with previous reports that pigmented strains of rats tend to be more resistant to HII (Rapp and Williams, 1980) . Throughout this study, the differences in sensitivity to melatonin and/or light treatments were quite small. By using a large number of animals in this study, we were we able to detect statistically significant differences between some treatment groups. One noteworthy feature of this study is that the relatively modest intensity and duration of light exposure was capable of inducing small but measurable differences between treatment groups. Although the observations that melatonin administration alone has some statistically significant toxic effects in some groups, some caution in interpreting these results is warranted. For example, there were some statistically significant differences between two groups that indicated that melatonin increased ONL thickness, which could be accounted for by tissue swelling. The evidence that melatonin increases the degree of HII-induced photoreceptor cell death is quite strong, whereas the evidence suggesting that melatonin administration alone is toxic to photoreceptor cells is rather weak, except for the toxic effect at night on pigmented males.
Melatonin administration increases the degree of photoreceptor cell death in response to environmental light exposure, but is also involved in the regulation of necessary circadian events that occur in the retina, such as photoreceptor outer segment disk shedding and phagocytosis (Besharse and Dunis, 1983; White and Fisher, 1989) , modulation of dopamine release (Dubocovich, 1983; Dubocovich and Takahashi, 1987) , and increased sensitivity of the retina to light (Wiechmann et al., 1988 (Wiechmann et al., , 2003 . Melatonin also delays photoreceptor degeneration in a dystrophic animal model (Liang et al., 2001) . The dichotomy of beneficial versus detrimental effects of melatonin may be the result of a cyclic rhythm of intracellular responsiveness to melatonin. We hypothesize that the circadian rhythm of melatonin synthesis reflects a beneficial role during the dark period, but is a potential hazard during exposure to light. In light of the evidence presented in this study, we suggest that it would be prudent for individuals to avoid chronic self-administration of melatonin in the presence of high levels of environmental illumination. The unanticipated observation that melatonin treatment potentially induces photoreceptor cell death during the night, when endogenous retinal melatonin levels are highest, raises new questions regarding the regulation and function of melatonin receptors in the retina.
